PMN recruitment in inflammatory lung injury models follows classical transendothelial migration paradigms requiring

Maureen E Haynes1, Erika Arias1, David P Sullivan1

  • 1Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.

Insights

Polymorphonuclear cells (PMNs) use PECAM-1 and CD99 to migrate into the lungs during inflammation. Blocking these molecules prevents PMN transmigration, clarifying immune cell recruitment in the lungs.

Area of Science:

  • Immunology
  • Cell Biology
  • Pulmonary Medicine

Background:

  • Immune cell recruitment to inflammation sites is a stepwise process.
  • Transendothelial migration in systemic circulation involves PECAM-1 and CD99.
  • Lung immune cell recruitment differs from the classical paradigm; transmigration is understudied.

Purpose of the Study:

  • To investigate the role of PECAM-1 and CD99 in polymorphonuclear cell (PMN) transmigration in the lung.
  • To elucidate the mechanisms of PMN extravasation in response to various lung injuries.

Main Methods:

  • Intravital microscopy (IVM) of pulmonary vasculature after induced lung injury (chemical, bacterial, ischemia/reperfusion).
  • Utilized blocking antibodies against PECAM-1 and CD99.
  • Quantified PMN transmigration in real time.

Main Results:

  • PMNs utilize PECAM-1 and CD99 for transmigration in response to chemical, bacterial, and ischemia/reperfusion lung injury.
  • PMN recruitment to bacterial infections is PECAM-1 and CD99 dependent.
  • Direct visualization confirmed PMN extravasation across alveolar capillaries.

Conclusions:

  • Classical transmigration proteins PECAM-1 and CD99 are essential for PMN entry into lung airspace.
  • Blocking PECAM-1 or CD99 inhibits PMN transmigration in lung inflammation models.
  • Findings clarify the molecular mechanisms of immune cell transmigration in the pulmonary system.